Clinical Trials Logo

Maternal Vaccine Exposure clinical trials

View clinical trials related to Maternal Vaccine Exposure.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03578120 Completed - Clinical trials for Immunization; Infection

Immunising Mums Against Pertussis 3

iMAP3
Start date: April 24, 2018
Phase:
Study type: Observational

This study will aim to recruit at least 70 children who participated in the iMAP2 study whose mothers received a pertussis vaccine in pregnancy as part of the iMAP2 trial and at least 15 children born to mothers who did not receive a pertussis vaccine in pregnancy. Blood samples will be obtained prior to and one month after the routine preschool booster vaccination and vaccine responses compared between children whose mothers received one of two pertussis vaccines or no pertussis vaccine in pregnancy. Children will be vaccinated with the routine booster vaccines by the study team on the same visit as the pre-vaccination bloods are taken.